Treatment response and safety of immunotherapy for advanced non-small cell lung cancer with comorbid chronic obstructive pulmonary disease: a retrospective cohort study

BACKGROUND: Immunotherapy has provided a novel therapeutic option for lung cancer but studies involving patients with advanced non-small cell lung cancer (NSCLC) coupled with various degrees of comorbid chronic obstructive pulmonary disease (COPD) are limited. Thus, we performed a retrospective coho...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Kening, Zhou, Chengzhi, Gao, Jiabo, Yu, Pei, Lin, Xinqing, Xie, Xiaohong, Liu, Ming, Zhang, Jiexia, Xie, Zhanhong, Cui, Fei, Li, Shiyue, Passiglia, Francesco, Stella, Giulia Maria, Qin, Yinyin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9742614/
https://www.ncbi.nlm.nih.gov/pubmed/36519030
http://dx.doi.org/10.21037/tlcr-22-667

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9742614/
https://www.ncbi.nlm.nih.gov/pubmed/36519030
http://dx.doi.org/10.21037/tlcr-22-667

Ejemplares similares